Eucare Pharmaceuticals

What Eucare Pharmaceuticals does

Eucare Pharmaceuticals (P) Ltd. is a privately held bio-pharmaceutical company incorporated in 1996 and headquartered in Chennai, Tamil Nadu, India. The company specializes in collagen-based medical devices and drug delivery systems, operating across five therapeutic categories: burns, wound care, surgical haemostasis, dental fillers and regeneration, and scar management. Its product portfolio includes bovine-based, fish-origin, and porcine-origin collagen membranes, particles and sponges (Kollagen, NeuSkin, BioFil, BioFil-AB, BioFil Sponge, GelSpon, Scrofalon), a silicone-based scar gel (Lysil), a collagen periodontal membrane (PerioCol-GTR), and synthetic nanocrystalline hydroxyapatite bone grafts (SyboGraf, SyboGraf-Plus). The company leverages TLC Technology — a patented jellified healing matrix licensed from Laboratoires Urgo — as the foundation of its advanced wound care solutions, and additionally distributes Laboratoires Urgo's medical product line in India under the 'Urgo Medical India' sub-brand.

Eucare generates revenue through direct sales of its medical device and pharmaceutical products via three primary channels: a domestic sales and government tender motion, an export and Own Brand Label (OBL) business for international markets, and an IndiaMART marketplace listing. Products are sold to hospitals, burn centers, dental clinics, surgical centers, and healthcare professionals treating burns, chronic wounds, infected sites, surgical bleeding, periodontal defects, and scars. Certain products are CE-marked (e.g., Scrofalon in the EU), while trademarks span India and EU jurisdictions, reflecting an attempt to commercialize in regulated export markets.

The company is founder or privately held, with no disclosed external funding rounds, institutional investors, or public listing. The leadership team includes Managing Director S. Sridharan, and headcount is reported at 1-10 employees. There is no publicly disclosed revenue figure, and no management team beyond the managing director is named in the available sources. Distribution relies on dedicated email and phone contacts for each sales motion rather than a large field sales force, suggesting a lean operating model where manufacturing and partnership-licensed technology (Urgo TLC) carry the technical burden.

Name

Eucare Pharmaceuticals

Legal name

Eucare Pharmaceuticals (P) Ltd.

Website

https://eucareindia.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1–10 employees

Short description

Eucare Pharmaceuticals (P) Ltd., founded 1996 in Chennai, India, is a private bio-pharmaceutical company that develops and sells collagen-based medical devices for burns, wound care, surgical haemostasis, dental regeneration, and scar management to healthcare facilities domestically and for export.

Ownership category

akta.pro rank

Product category

Collagen-based Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

akta.pro secondary industries

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film) (HLAHALAA)

Keywords

• Collagen medical devices
• Wound care products
• Burn treatment membranes
• Surgical haemostatic agents
• Dental bone grafts

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device/Pharmaceutical Product Sales: Eucare generates revenue through the sale of collagen-based medical devices and pharmaceutical products including burn treatments, wound care products, surgical haemostats, dental fillers, and scar management products. Products are sold domestically, through tenders, and for export.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Eucare Pharmaceuticals manufactures and sells collagen-based medical devices and drug delivery products for burn treatment, advanced wound care, surgical haemostasis, dental bone grafting/regeneration, and scar management. The portfolio covers collagen membranes (Kollagen, NeuSkin, Kollagen-D, PerioCol-GTR), collagen particles and sponges (BioFil, BioFil-AB, BioFil Sponge), haemostatic gelatin sponges (GelSpon, Scrofalon), synthetic and biphasic bone grafts (SyboGraf, SyboGraf-Plus), and silicone gel sheets (Lysil/Lysil-Gel). Products are sold directly to hospitals, clinics and surgical centers domestically, through government tenders, via exports/OBL, and through the IndiaMART B2B marketplace.

Product overview

Eucare Pharmaceuticals is a Bio-Pharmaceutical company incorporated in 1996 from Chennai, India, specializing in Collagen technologies and Drug delivery systems. Their product portfolio is organized into five therapeutic categories: Burns (Kollagen®, NeuSkin™, Kollagen®-D), WoundCare (BioFil®, BioFil®-AB, BioFil® Sponge), Scar Management (Lysil™), Haemostat (GelSpon®, Scrofalon®), and Dental (PerioCol®-GTR, SyboGraf®, SyboGraf®-Plus). The company leverages proprietary TLC Technology licensed from Laboratoires Urgo, which forms the foundation of their advanced wound care solutions. Their products are distributed under various brand architectures including Kollagen®, BioFil®, NeuSkin™, Lysil™, GelSpon®, Scrofalon®, PerioCol®-GTR, and SyboGraf® brands.

Differentiator

Problem solved

Functional benefit

Brands

• Urgo Medical India: Partnership/distribution relationship with Laboratoires Urgo for medical products in India market.

Products and services

• Kollagen Bovine-based extracellular matrix native collagen membrane that acts as a skin substitute for treating superficial and deep dermal burns in a cost-effective way. Targeted at hospitals and burn centers.
• NeuSkin Collagen membrane for burn treatment, offered in freeze-dried form to avoid pre-treatment in normal saline before application, gamma sterilized and available in different dimensions. Used by hospitals and burn units.
• Kollagen-D Sterile porous collagen dressing made from intact Type 1 collagen of fish origin with a porous matrix structure combined with a nylon mesh layer. Used as primary collagen dressing for partial thickness burns and wounds and as a matrix for tissue regeneration. Targeted at hospitals and burn centers.
• BioFil Sterile collagen particles used for treating various wounds including acute chronic ulcers and diabetic ulcers. Used by hospitals and wound care clinics.
• BioFil-AB Sterile medicated collagen particles impregnated with mupirocin USP 2% w/w and metronidazole IP 1% w/w, used for treating difficult and chronic wound conditions and grossly infected sites. Targeted at hospitals and wound care clinics.
• BioFil Sponge Sterile collagen sponge used for treating cavity wounds, exuding wounds and venous stasis ulcers. Used by hospitals and wound care clinics.
• Lysil & Lysil-Gel Silicone gel sheet composed of soft, semi-occlusive polysiloxane material with excellent biocompatibility. Used for scar management by promoting hydration of stratum corneum to flatten and fade scars. Used by hospitals, burn centers and dermatology/plastic surgery clinics.
• GelSpon Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material from bovine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.
• Scrofalon Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material exclusively from porcine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.
• PerioCol-GTR Type 1 collagen membrane of fish origin for Guided Tissue Regeneration (GTR) applications with excellent handling characteristics and cost effectiveness. Used by dental clinics and periodontal specialists.
• SyboGraf Sterile synthetic nanocrystalline Hydroxyapatite bone graft material synthetically prepared using a novel patented biomimetic process technology in powder/granule form. Used by dental clinics, oral surgeons and bone grafting specialists.
• SyboGraf-Plus Biphasic bone graft composite prepared in-situ combining 70% Hydroxyapatite and 30% Beta-tricalcium phosphate. The faster resorption of Beta-TCP helps in bone mineralization while Hydroxyapatite provides scaffold for calcification. Used by dental clinics and oral surgeons.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Laboratoires UrgocoreTechnology or IntegrationEucare has a partnership with Laboratoires Urgo for access to TLC Technology - an exclusive innovation patented by Laboratoires Urgo. TLC healing matrix is a jellified healing matrix of hydrocolloid, fatty particles and polymers that promotes optimized wound healing. This technology is the core of all Urgo Medical products and is compatible with different materials including contact layer, fibres, and can be associated with compounds such as NOSF or silver. Eucare also distributes Urgo Medical products in India under the 'Urgo Medical India' brand.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Organogenesis: U.S. regenerative medicine company specializing in bioactive and acellular biomaterial products for wound care and surgical applications. Comparable as a specialist in biologic skin/wound healing technologies.
• MiMedx: U.S. company commercializing placental tissue allografts and regenerative wound care products. Comparable in the skin substitute and biologic wound healing space.

Broad incumbents

• Smith & Nephew: Global medical device company with a sizable Advanced Wound Management division. Directly comparable in collagen/skin substitute and advanced wound dressing categories.
• Mölnlycke Health Care: Swedish wound care and surgical solutions company with significant presence in advanced wound dressings. Comparable in the wound care and surgical hemostasis categories where Eucare competes.
• Integra LifeSciences: U.S. medical device company with a dedicated regenerative tissue technology portfolio including collagen-based dermal matrices and wound care. Highly comparable to Eucare's collagen membrane and skin substitute products.
• Laboratoires Urgo: French global wound care major and Eucare's strategic technology partner. Directly comparable as a collagen/advanced wound care company, and the licensor of the TLC Technology that underpins a number of Eucare's products.
• ConvaTec: Global wound care, ostomy, and continence care major. Competes with Eucare in advanced wound dressings and skin substitutes from an international scale.
• Coloplast: Danish multinational focused on wound care, ostomy, and skin substitutes. Comparable as a major player in advanced wound care and skin regeneration products.
• 3M (Health Care / KCI): Global diversified healthcare major with a substantial wound care and skin health portfolio (including the legacy KCI negative pressure wound therapy franchise). Comparable in advanced wound dressings and burn care.

Regional players

• Healthium Medtech: Indian medical device company with a portfolio covering wound care, surgical sutures, and orthopedics. Comparable as an India-based specialty medical device manufacturer targeting both domestic and export markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eucare Pharmaceuticals